Helixmith Co. Ltd
Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological… Read more
Helixmith Co. Ltd (084990) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.007x
Based on the latest financial reports, Helixmith Co. Ltd (084990) has a cash flow conversion efficiency ratio of -0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.00 Billion) by net assets (₩138.57 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Helixmith Co. Ltd - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Helixmith Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Helixmith Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Helixmith Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cool Company Oy
OL:CLCO
|
0.045x |
|
Hooker Furniture Corporation
NASDAQ:HOFT
|
0.028x |
|
Becamex Infrastructure Development JSC
VN:IJC
|
-0.044x |
|
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671
|
-0.212x |
|
Nanjing OLO Home Furnishing
SHG:603326
|
0.055x |
|
MNRB Holdings Bhd
KLSE:6459
|
0.065x |
|
Federal Corp
TW:2102
|
-0.009x |
|
Daqing Huake Co Ltd
SHE:000985
|
0.076x |
Annual Cash Flow Conversion Efficiency for Helixmith Co. Ltd (2010–2024)
The table below shows the annual cash flow conversion efficiency of Helixmith Co. Ltd from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩142.04 Billion | ₩-16.72 Billion | -0.118x | +30.11% |
| 2023-12-31 | ₩153.72 Billion | ₩-25.89 Billion | -0.168x | +10.38% |
| 2022-12-31 | ₩216.80 Billion | ₩-40.74 Billion | -0.188x | -10.96% |
| 2021-12-31 | ₩225.35 Billion | ₩-38.16 Billion | -0.169x | +2.54% |
| 2020-12-31 | ₩276.30 Billion | ₩-48.01 Billion | -0.174x | +17.25% |
| 2019-12-31 | ₩195.57 Billion | ₩-41.07 Billion | -0.210x | -108.92% |
| 2018-12-31 | ₩133.87 Billion | ₩-13.46 Billion | -0.101x | -538.11% |
| 2017-12-31 | ₩164.45 Billion | ₩-2.59 Billion | -0.016x | -9.76% |
| 2016-12-31 | ₩170.93 Billion | ₩-2.45 Billion | -0.014x | -188.31% |
| 2015-12-31 | ₩67.20 Billion | ₩1.09 Billion | 0.016x | +9598.28% |
| 2013-12-31 | ₩66.97 Billion | ₩11.22 Million | 0.000x | +100.30% |
| 2012-12-31 | ₩64.45 Billion | ₩-3.58 Billion | -0.056x | -26.50% |
| 2011-12-31 | ₩49.78 Billion | ₩-2.19 Billion | -0.044x | +12.11% |
| 2010-12-31 | ₩52.72 Billion | ₩-2.64 Billion | -0.050x | -- |